In February 2025, the Union Ministry of Health and Family Welfare (MoHFW) published a draft notification proposing to amend Rule 43A of the Drugs Rules, 1945, expanding the list of designated entry points for imported cosmetics, medical devices, and active ingredients into India. The proposed amendment adds Noida International Airport alongside strategic Inland Container Depots (ICDs) across Haryana, Uttar Pradesh, Gujarat, Telangana, and Karnataka to the country's official import schedule.
Rule 43A of the Drugs Rules, 1945 legally mandates specific entry ports for cosmetics and healthcare products to enforce national regulatory standards. By restricting legal entry to a designated schedule of sea and air ports, the framework concentrated clearance volume at primary coastal and metropolitan hubs. Shipments intended for manufacturing plants or retail channels in regional industrial belts were forced to clear initial customs at coastal points before undergoing secondary domestic transit.
The Metro Bottleneck
For importers of finished cosmetic goods and active raw ingredients, this restricted entry network added days to import cycles and inflated freight costs for beauty brands and ingredient suppliers. High transit costs, port congestion at major coastal gateways, and extended regulatory clearance delays consistently slowed shipments entering the country.
By restricting legal entry to primary metro hubs, Rule 43A created structural congestion at maritime borders. Cargo bound for manufacturing facilities or distribution centres in inland states routinely sat in coastal administrative queues, accumulating demurrage fees and extending lead times before raw materials or finished stock could move to regional industrial locations.
Moving Customs to the Clusters
The proposed amendment targets major manufacturing and consumption hubs, placing designated entry points closer to regional industrial clusters. Adding Noida International Airport alongside Inland Container Depots across five key states aligns statutory import gateways with modern freight logistics infrastructure.
The inclusion of ICDs in Haryana, Uttar Pradesh, Gujarat, Telangana, and Karnataka decentralises physical entry. Rather than holding goods at traditional maritime points, incoming freight can move under customs bond directly to inland container depots located closer to final distribution networks and production facilities.
According to the MoHFW draft notification, adding these strategic ICDs and airport infrastructure aims to reduce logistics bottlenecks, lower freight transit costs, and streamline customs and regulatory clearance for importers. The proposed changes arrive as India’s market for imported premium and specialty beauty products experiences steady expansion, driving higher volumes of both finished retail stock and raw active ingredients through national border controls.
The Inspectorate Gap
Under Indian cosmetic regulations, physical importation requires strict verification against product registration certificates issued by the Central Drugs Standard Control Organisation (CDSCO). Expanding the list of designated entry points requires matching regulatory infrastructure at each new location to prevent non-compliant or unregistered goods from entering domestic supply chains.
The MoHFW draft has not named the specific ministry officials driving the notification, nor has it detailed the administrative schedule for establishing CDSCO inspection booths at each newly listed inland container depot.
The Ministry has not yet set a closing date for public comment or a timeline for final implementation. Whether the Central Drugs Standard Control Organisation can post qualified inspectors to every new depot on day one, or whether clearance capabilities will roll out in phased stages based on inspector availability, remains the key operational risk.